(Q50561807)

15 March 2018

title

Interferon-alfa, interferon-lambda and hepatitis C. (English)

1 reference

15 March 2018

author name string

Thomas R O'Brien

series ordinal

1

1 reference

15 March 2018

language of work or name

English

0 references

publication date

13 September 2009

1 reference

15 March 2018

published in

Nature Genetics

1 reference

15 March 2018

volume

41

1 reference

15 March 2018

issue

10

1 reference

15 March 2018

page(s)

1048-1050

1 reference

15 March 2018

IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNG.453

IL-28, IL-29 and their class II cytokine receptor IL-28R

21 January 2018

1 reference

12 December 2020

Chronic hepatitis C virus infection: genotyping and its clinical role

1 reference

12 December 2020

Beyond odds ratios — communicating disease risk based on genetic profiles

1 reference

12 December 2020

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

12 December 2020

NIH Consensus Statement on Management of Hepatitis C: 2002

1 reference

12 December 2020

Lambda interferon inhibits hepatitis B and C virus replication

1 reference

12 December 2020

Global epidemiology of hepatitis C virus infection

1 reference

12 December 2020

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

1 reference

12 December 2020

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

1 reference

12 December 2020

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

1 reference

12 December 2020

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics

1 reference

12 December 2020

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNG.453

7 January 2021

inferred from DOI database lookup

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNG.453

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NG.453

1 reference

15 March 2018

1 reference

15 March 2018